S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.74 (-1.51%)
NIO   3.87 (-3.25%)
BABA   68.78 (-0.15%)
T   16.38 (+0.31%)
F   12.16 (+0.83%)
MU   109.98 (-1.74%)
GE   152.66 (-0.18%)
CGC   8.20 (+4.73%)
DIS   111.97 (-0.41%)
AMC   3.12 (+6.85%)
PFE   25.40 (+0.04%)
PYPL   62.12 (+0.03%)
XOM   120.10 (+1.33%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.74 (-1.51%)
NIO   3.87 (-3.25%)
BABA   68.78 (-0.15%)
T   16.38 (+0.31%)
F   12.16 (+0.83%)
MU   109.98 (-1.74%)
GE   152.66 (-0.18%)
CGC   8.20 (+4.73%)
DIS   111.97 (-0.41%)
AMC   3.12 (+6.85%)
PFE   25.40 (+0.04%)
PYPL   62.12 (+0.03%)
XOM   120.10 (+1.33%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.74 (-1.51%)
NIO   3.87 (-3.25%)
BABA   68.78 (-0.15%)
T   16.38 (+0.31%)
F   12.16 (+0.83%)
MU   109.98 (-1.74%)
GE   152.66 (-0.18%)
CGC   8.20 (+4.73%)
DIS   111.97 (-0.41%)
AMC   3.12 (+6.85%)
PFE   25.40 (+0.04%)
PYPL   62.12 (+0.03%)
XOM   120.10 (+1.33%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.74 (-1.51%)
NIO   3.87 (-3.25%)
BABA   68.78 (-0.15%)
T   16.38 (+0.31%)
F   12.16 (+0.83%)
MU   109.98 (-1.74%)
GE   152.66 (-0.18%)
CGC   8.20 (+4.73%)
DIS   111.97 (-0.41%)
AMC   3.12 (+6.85%)
PFE   25.40 (+0.04%)
PYPL   62.12 (+0.03%)
XOM   120.10 (+1.33%)
NASDAQ:XXII

22nd Century Group (XXII) Stock Price, News & Analysis

$1.69
-0.02 (-1.17%)
(As of 10:04 AM ET)
Today's Range
$1.61
$1.69
50-Day Range
$1.48
$43.01
52-Week Range
$1.45
$180.91
Volume
91,006 shs
Average Volume
1.22 million shs
Market Capitalization
$5.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$100.00

22nd Century Group MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
5,748.0% Upside
$100.00 Price Target
Short Interest
Healthy
5.58% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.04mentions of 22nd Century Group in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.27 out of 5 stars

XXII stock logo

About 22nd Century Group Stock (NASDAQ:XXII)

22nd Century Group, Inc., a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands. The company was founded in 1998 and is headquartered in Mocksville, North Carolina.

XXII Stock Price History

XXII Stock News Headlines

Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
22nd Century Group Inc
Notable earnings before Thursday's open
XXII May 2024 2.000 put
XXII Jan 2026 0.500 put
XXII Mar 2024 0.500 put
XXII Jul 2024 1.000 call
MO Mar 2024 37.500 put
PM Mar 2024 91.000 put
Stocks open higher coming off of Thursday's Nvidia rally
MO Mar 2024 40.500 put
See More Headlines
Receive XXII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 22nd Century Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/04/2021
Today
4/19/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Cigarettes
Sub-Industry
Cannabis
Current Symbol
NASDAQ:XXII
Employees
64
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$100.00
High Stock Price Target
$120.00
Low Stock Price Target
$80.00
Potential Upside/Downside
+5,748.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$-140,770,000.00
Net Margins
-167.13%
Pretax Margin
-169.66%

Debt

Sales & Book Value

Annual Sales
$32.20 million
Book Value
($3.09) per share

Miscellaneous

Free Float
3,469,000
Market Cap
$5.95 million
Optionable
Optionable
Beta
1.53
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

XXII Stock Analysis - Frequently Asked Questions

Should I buy or sell 22nd Century Group stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for 22nd Century Group in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" XXII shares.
View XXII analyst ratings
or view top-rated stocks.

What is 22nd Century Group's stock price target for 2024?

4 equities research analysts have issued 12 month target prices for 22nd Century Group's stock. Their XXII share price targets range from $80.00 to $120.00. On average, they predict the company's share price to reach $100.00 in the next twelve months. This suggests a possible upside of 5,748.0% from the stock's current price.
View analysts price targets for XXII
or view top-rated stocks among Wall Street analysts.

How have XXII shares performed in 2024?

22nd Century Group's stock was trading at $47.6672 at the beginning of the year. Since then, XXII shares have decreased by 96.4% and is now trading at $1.71.
View the best growth stocks for 2024 here
.

Are investors shorting 22nd Century Group?

22nd Century Group saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 192,000 shares, a decrease of 92.2% from the March 15th total of 2,450,000 shares. Based on an average daily trading volume, of 1,350,000 shares, the short-interest ratio is currently 0.1 days. Approximately 5.6% of the shares of the company are sold short.
View 22nd Century Group's Short Interest
.

When is 22nd Century Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our XXII earnings forecast
.

How were 22nd Century Group's earnings last quarter?

22nd Century Group, Inc. (NASDAQ:XXII) posted its quarterly earnings data on Thursday, November, 4th. The biotechnology company reported ($230.40) EPS for the quarter, missing analysts' consensus estimates of ($153.60) by $76.80. The biotechnology company earned $7.81 million during the quarter, compared to the consensus estimate of $8 million. 22nd Century Group had a positive trailing twelve-month return on equity of 7.51% and a negative net margin of 167.13%.

What ETF holds 22nd Century Group's stock?

Amplify Alternative Harvest ETF holds 12,679 shares of XXII stock, representing 0.01% of its portfolio.

When did 22nd Century Group's stock split?

22nd Century Group's stock reverse split on the morning of Tuesday, April 2nd 2024. The 1-16 reverse split was announced on Tuesday, April 2nd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, April 2nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

What other stocks do shareholders of 22nd Century Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 22nd Century Group investors own include Aurora Cannabis (ACB), Alteryx (AYX), Auxly Cannabis Group (CBWTF), Charlotte's Web (CWBHF), Enphase Energy (ENPH), Inseego (INSG), Luckin Coffee (LKNCY), MediPharm Labs (MEDIF) and MercadoLibre (MELI).

How do I buy shares of 22nd Century Group?

Shares of XXII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:XXII) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners